RxDoctor Payments Data

Diane Brown

Adult Health · Hamlet, NCNPI 1063636728

Payments from drug & device makers

$1,049in general payments, 2019–2025

Across 66 payments — averaging $15.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$236
  • GSK$167
  • Novo Nordisk$123
  • AstraZeneca$103
  • Merck$84
  • Phathom Pharmaceuticals, Inc.$68
  • plus $269 from 8 others

What the payments were for

  • Food & beverage$1,049100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,049 in reported general payments places this provider in the 65th percentile of 614 adult health providers in North Carolina.

See all adult health providers in North Carolina

Medicare billing

Part B allowed, 2024
$31,773
Medicare patients
119
Services billed
565

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin58$75,688
TrulicityDulaglutide58$73,036
OzempicSemaglutide56$62,034
MounjaroTirzepatide29$36,542
Trelegy ElliptaFluticasone/Umeclidin/Vilanter42$35,087
EliquisApixaban24$19,707
ProcritEpoetin Alfa11$13,420
TrintellixVortioxetine Hydrobromide17$12,710
Topiramate ErTopiramate21$7,841
NexiumEsomeprazole Magnesium13$7,609
Breo ElliptaFluticasone/Vilanterol15$6,112
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$6,069
Tresiba Flextouch U-100Insulin Degludec11$5,323
VascepaIcosapent Ethyl11$4,039
SymbicortBudesonide/Formoterol Fumarate15$3,967

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$236$109,57887 claims
Boehringer IngelheimJardiance$15$75,68858 claims
Novo NordiskOzempic$123$62,03456 claims
GSKTrelegy Ellipta, Breo Ellipta$167$41,19957 claims
PfizerEliquis$54$19,70724 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$14$12,71017 claims
AstraZenecaNexium, Symbicort$103$11,57628 claims
ANI Pharmaceuticals, Inc.Valsartan$39$1,62484 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 614 adult health providers in North Carolina.

Other adult health in Hamlet

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →